CHICAGO—Patients with diabetic gastroparesis who are treated with nasal metoclopramide have fewer office visits, emergency room visits and hospital admissions than those given an oral formulation of the drug, according to a retrospective study of real-world patients.
This type of analysis cannot determine why the nasal formulation was associated with reduced use of resources, but “we hypothesize that the advantage is due to better symptom control,” reported investigator David